Basis for Breast Cancer Diagnosis
The diagnosis of breast cancer is primarily based on the following workflow:
1. Clinical presentation assessment
Through medical history taking and physical examination, clinicians assess symptoms such as a painless mass, skin changes, or nipple discharge.
2. Breast ultrasonography
A noninvasive imaging modality used to evaluate the characteristics and nature of a breast mass and the status of axillary lymph nodes.
3. Mammography
Breast X-ray imaging is an important screening tool, particularly for detecting early microcalcifications in women aged 40 years and older.
4. Magnetic resonance imaging
A highly sensitive modality commonly used to accurately assess tumor extent, multifocal disease, and preoperative planning.
5. Histopathological biopsy
The diagnostic gold standard; tissue sampling is used to confirm tumor type and subtype.
6. Immunohistochemistry
Assessment of biomarkers such as ER, PR, and HER2 provides a basis for molecular subtyping and targeted therapy selection.
7. Sentinel lymph node biopsy
Used to evaluate axillary nodal metastasis and helps avoid unnecessary extensive axillary dissection.
Conclusion: Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that breast cancer poses a serious threat to women’s health, and late-stage diagnosis adversely affects treatment outcomes. Early diagnosis is pivotal: regular screening, together with imaging and pathological examinations, should be used to enable early detection. Treatment should then be individualized based on stage and molecular subtype, integrating surgery and minimally invasive approaches to substantially improve cure rates and quality of survival.
Basis for Breast Cancer Diagnosis
The diagnosis of breast cancer is primarily based on the following workflow:
1. Clinical presentation assessment
Through medical history taking and physical examination, clinicians assess symptoms such as a painless mass, skin changes, or nipple discharge.
2. Breast ultrasonography
A noninvasive imaging modality used to evaluate the characteristics and nature of a breast mass and the status of axillary lymph nodes.
3. Mammography
Breast X-ray imaging is an important screening tool, particularly for detecting early microcalcifications in women aged 40 years and older.
4. Magnetic resonance imaging
A highly sensitive modality commonly used to accurately assess tumor extent, multifocal disease, and preoperative planning.
5. Histopathological biopsy
The diagnostic gold standard; tissue sampling is used to confirm tumor type and subtype.
6. Immunohistochemistry
Assessment of biomarkers such as ER, PR, and HER2 provides a basis for molecular subtyping and targeted therapy selection.
7. Sentinel lymph node biopsy
Used to evaluate axillary nodal metastasis and helps avoid unnecessary extensive axillary dissection.
Conclusion: Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that breast cancer poses a serious threat to women’s health, and late-stage diagnosis adversely affects treatment outcomes. Early diagnosis is pivotal: regular screening, together with imaging and pathological examinations, should be used to enable early detection. Treatment should then be individualized based on stage and molecular subtype, integrating surgery and minimally invasive approaches to substantially improve cure rates and quality of survival.